| |
|||
| What is biopharmaceutical industry doing with Key Account Management across Europe? | |||
| The Cegedim RM Key Account Management best practices survey explores the Life Sciences KAM trends | |||
| In parternership with: |
![]() |
![]() |
|
1. Do you represent an affiliate or an HQ organization?![]() 2. Where are you based? ![]() 3. What is your current position? ![]() 4. Which of the following describes your organization’s involvement in KAM? (one answer only) ![]() 5. In which of the following customer environments do you implement KAM? (several answers possible) ![]() 6. Which of the following benefits are you expecting from KAM? (several answers possible) ![]() 7. As you have attempted to implement KAM, which of the following topics have proved to be challenges? If you are only starting implementation, then which do you anticipate being challenges? ![]() 8. When considering tools and data to support KAM initiatives, how do you value the following attributes? ![]() 9. UK respondents only: Do you believe that the UK Government’s proposed changes to the NHS will have a significant impact on your KAM Strategy ? ![]() 10. UK respondents only. From what you know of the proposed changes to the NHS, how do you expect the level of KAM resource to be impacted? ![]() |
|||